DePuy Hip Deformity Rate Was Alarming, Expert Tells Jury

By Ciaran McEvoy (February 6, 2013, 3:30 PM EST) -- Johnson & Johnson subsidiary DePuy Inc.'s ASR XL hip implants deformed up to 10 times more than recommended by the hip replacement industry, a biomedical engineering expert told a jury Wednesday in a trial accusing DePuy of selling replacement hips with excessive failure rates.

Dr. J. Dennis Bobyn, a professor of biomedical engineering and surgery at McGill University in Montreal, told a Los Angeles jury that such a high rate of deformity among DePuy's metal hip implants should have raised a "red flag" at the company. Testing showed the issue in 2003, before the implants were sold on the market, Bobyn...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!